Business
AIxCrypto Holdings Reports Full Year 2025 Financial Results; Highlights Transformational Pivot to AI and Blockchain Infrastructure
LOS ANGELES, March 24, 2026 /PRNewswire/ -- AIxCrypto Holdings, Inc. (NASDAQ: AIXC, or the "Company"), today reported financial results for the fiscal year
About this update from Aixcrypto Holdings, Inc.
[{"type":"text","content":"LOS ANGELES, March 24, 2026 /PRNewswire/ -- AIxCrypto Holdings, Inc. (NASDAQ: AIXC, or the \"Company\"), today reported financial results for the fiscal year ended December 31, 2025 — its inaugural annual earnings release following its transformation from a clinical-stage biopharmaceutical company into an AI and blockchain-enabled digital infrastructure company spanning Real World Asset (RWA) tokenization, AI agents and Embodied AI (EAI) blockchain ecosystems, connecting Web2 and Web3.\nFiscal year 2025 was principally a period of strategic repositioning, capital formation, and platform development. The Company closed a $41.0 million private placement, rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025, assembled an entirely new executive leadership team, and began building infrastructure for its Real World Asset tokenization, AI agents and Embodied AI blockchain ecosystem businesses, enabling intelligent devices such as robots, smart vehicles, and drones to autonomously collaborate and execute tasks through Agents, and driving the silicon-based economy from concept to reality.Management's complete discussion of results and risks is contained in the Annual Report on Form 10-K to be filed shortly with the Securities and Exchange Commission.FISCAL YEAR 2025 HIGHLIGHTSStrategic Repositioning and Capital FormationCompleted $41.0 million PIPE financing: In September 2025, the Company consummated a subscription agreement with investors including Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) as lead investor, strengthened the Company's balance sheet.Rebrand and Nasdaq debut: On November 20, 2025, the Company was officially renamed from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. and began trading on the Nasdaq Capital Market under the ticker symbol AIXC.New executive leadership team: Concurrent with the PIPE closing, a new management team was appointed, including Co-Chief Executive Officer Jerry Wang and Chief Financial Officer Koti Meka, combining Web2 and Web3 expertise.Platform and EcosystemDevelopment of the AI Agent & EAI blockchain ecosystem: the Company completed the initial strategic planning of the AI Agent and EAI ecosystem together with the AIXC Foundation, and completed the planning and initial setup of the AI Agent & EAI ecosystem, including:Application layer – com...